Scientists aim to zap esophageal cancer with stronger, targeted radiation
NCT ID NCT07359417
Summary
This early-stage trial is testing if giving a higher, more precise dose of radiation can better control a type of esophageal cancer. It will involve about 30 patients who are already scheduled for standard chemotherapy, radiation, and surgery. The main goal is to find the highest safe dose of this boosted radiation that doesn't cause severe side effects, with the hope of improving treatment outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584CX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.